Teva, Mylan Eye Pfizer’s Generic Venture in Brazil

According to Reuter's sources, Teva Pharmaceutical and Mylan have shown early interest in a Brazilian generic drugmaking joint-venture, Laboratório Teut|Pfizer, in which Pfizer Inc has a 40 percent stake

Source: Pharma Manufacturing
More...